Oct 16, 2021

A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study

Here's the herbal formula NRICM101, aka 清冠一號, developed in May 2020 to treat covid-19 patients with mild symptoms. This research article "A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study" is published in January 2021. The clinical research of this article is conducted at Tri-service General Hospital and Taichung Veteran General Hospital.

There was an outbreak in Taiwan starting mid-May and thankfully we are fine now. I am glad we had more experience in treating covid-19 patients after May with herbal medicine at Tri-service General Hospital. More clinical data is going to be published soon. 

Here's more info on NRICM101:





May 31, 2021

台灣清冠一號 NRICM101

NRICM101 is a Traditional Chinese herbal medicine formula developed by National Research Institute of Chinese Medicine in Taiwan to treat covid-19 patients.

Here's some info about NRICM101:

FAQs on NRICM101 (with English translation)

Here's more info in Chinese


Some Media coverage:

Fast track to approve traditional Chinese medicine ‘NRICM101’ for COVID

臺灣清冠一號:蘇奕彰所長講解清冠一號研發到緊急授權藥證的過程,澄清民眾的誤解。

防疫中藥 清冠一號 阻斷病毒!舉平手養生操平衡免疫  (Dr. Huang is our department chief)

熱線追蹤 - 防疫中藥 清冠一號

June 2021 Clinic Hours

Because of the increasing Covid-19 confirmed cases in Taiwan since mid-May, our department has stopped all the acupuncture treatment for both inpatients and outpatients. Herbal medicine is still available. Many patients came to us for NRICM101 and I personally take this formula since we have a higher risk of being infected

I hope we can all get vaccinated soon and please wear masks all the time and wash hands frequently.